MX2022007217A - Vacuna epitópica para virus de fiebre porcina africana. - Google Patents

Vacuna epitópica para virus de fiebre porcina africana.

Info

Publication number
MX2022007217A
MX2022007217A MX2022007217A MX2022007217A MX2022007217A MX 2022007217 A MX2022007217 A MX 2022007217A MX 2022007217 A MX2022007217 A MX 2022007217A MX 2022007217 A MX2022007217 A MX 2022007217A MX 2022007217 A MX2022007217 A MX 2022007217A
Authority
MX
Mexico
Prior art keywords
polypeptides
fever virus
cell epitope
swine fever
african swine
Prior art date
Application number
MX2022007217A
Other languages
English (en)
Inventor
Groot Anne De
William Martin
Lenny Moise
Andres Gutierrez
Original Assignee
Epivax Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Epivax Inc filed Critical Epivax Inc
Publication of MX2022007217A publication Critical patent/MX2022007217A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C07K14/01—DNA viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/12011—Asfarviridae
    • C12N2710/12022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/12011—Asfarviridae
    • C12N2710/12034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Abstract

La presente divulgación se refiere de manera general a compuestos y composiciones de epítopos de células T eficaces contra virus de fiebre porcina africana (¿ASFV¿) y enfermedades relacionadas. Tales compuestos y composiciones de epítopos de células T incluyen polipéptidos de epítopos de células T inmunogénicos (que incluyen polipéptidos concateméricos y polipéptidos quiméricos o de fusión), así como ácidos nucleicos, plásmidos, vectores y células que expresan los polipéptidos, composiciones farmacéuticas y vacunas, y los usos de los mismos. La presente divulgación es adecuada en particular para producir vacunas para animales no humanos, en particular para vacunar cerdos contra infección de ASFV y enfermedades relacionadas.
MX2022007217A 2019-12-11 2020-12-11 Vacuna epitópica para virus de fiebre porcina africana. MX2022007217A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962946714P 2019-12-11 2019-12-11
US202063034567P 2020-06-04 2020-06-04
PCT/US2020/064507 WO2021119424A1 (en) 2019-12-11 2020-12-11 Epitopic vaccine for african swine fever virus

Publications (1)

Publication Number Publication Date
MX2022007217A true MX2022007217A (es) 2022-09-12

Family

ID=76330573

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2022007217A MX2022007217A (es) 2019-12-11 2020-12-11 Vacuna epitópica para virus de fiebre porcina africana.

Country Status (4)

Country Link
US (1) US20230192777A1 (es)
CA (1) CA3161222A1 (es)
MX (1) MX2022007217A (es)
WO (1) WO2021119424A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114437236B (zh) * 2022-01-11 2023-06-27 中国农业科学院兰州兽医研究所 一种重组非洲猪瘟病毒多表位融合蛋白、制备及其应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2337113B1 (es) * 2007-04-17 2011-01-24 Centre De Recerca En Sanitat Animal (Cresa) Empleo de la hemaglutinina del virus de la peste porcina africana como adyuvante.

Also Published As

Publication number Publication date
CA3161222A1 (en) 2021-06-17
WO2021119424A1 (en) 2021-06-17
US20230192777A1 (en) 2023-06-22

Similar Documents

Publication Publication Date Title
MX2019005268A (es) Vacuna peptidica para prevencion e inmunoterapia de la demencia tipo alzheimer.
ATE85622T1 (de) Chimarenglykoproteine, enthaltend immunogene segmente des humanen respiratorischen synzytialvirus.
ME00183B (me) Novi postupak za deregulaciju amiloida
WO2016007576A8 (en) Novel vaccine compositions for porcine epidemic diarrhea virus and porcine deltacoronavirus
ATE527281T1 (de) Impfstoffe gegen aids umfassend cmv/r nucleinsäurekonstrukte
DK1968632T3 (da) Forbedret influenzavaccine
KR890701770A (ko) 호흡성 신시아 비루스 : 백신 및 진단검사법
HK1120730A1 (en) Nipah virus vaccines nipah
RU2015138530A (ru) Комбинированная вакцина против респираторно-синцитиального вируса и вируса гриппа
CY1120430T1 (el) Ανασυνδυασμενες cdv συνθεσεις και χρησεις αυτων
AR110632A1 (es) Vectores del adenovirus canino
HRP20230752T1 (hr) Cjepivo protiv slinavke i šapa
MX2022007217A (es) Vacuna epitópica para virus de fiebre porcina africana.
AR108014A1 (es) Vacuna universal para enfermedades virales y método de vacunación
WO2018066999A3 (en) Chimeric enterovirus virus-like particles
EA202190778A1 (ru) Композиция комбинированной вакцины, содержащая уменьшенную дозу инактивированного полиовируса, и способ её получения
RU2018122755A (ru) Слитые белки fmdv-e2 и их применение
CA2970158A1 (en) Synergistic co-administration of computationally optimized broadly reactive antigens for h1n1 influenza
WO2007098717A3 (es) Antígenos vacunales quiméricos contra el virus de la peste porcina clásica
MX2010003220A (es) Proteinas inmunogenicas de membrana exterior derivada de genoma de leptospira y composiciones y metodos basados en las mismas.
KR101937792B1 (ko) 신규한 재조합 항원 단백질을 포함하는 구제역 백신 조성물
ES2063897T3 (es) Vacuna contra el virus del colera porcino y diagnostico.
FR2829498B1 (fr) Igf-1 comme adjuvant de vaccin felin, notamment contre les retrovirus felins
WO2017116177A3 (ko) 약독화된 돼지열병 바이러스 생마커백신주 및 이를 이용한 경구투여용 백신 조성물
TN2014000393A1 (en) Modified marek's disease virus, and vaccines made therefrom